Abstract:Objective To analyze the application value of home atomization inhaled glucocorticoids in the treatment of pediatric respiratory diseases.Methods Slected 90 cases of pediatric respiratory disease patient in our hospital from June 2015 to June 2017,and divided into routine group(45 cases)and experimental group(45 cases)randomly according to computer machine selection,the control group was received routine treatment,the experimental group was received the treatment of home atomization inhaled glucocorticoids.The improvement of clinical symptoms in the two groups was observed,and the family satisfaction and the total effective rate of treatment were analyzed and compared.Results The total effective rate of the treatment in the experimental group was 95.56% (43/45),the total effective rate of the treatment in routine group was 84.44%(38/45),the effect of experimental group was significantly higher than that the routine group,comparison between groups with statistical significance(P<0.05).The experimental group both in the wheezing disappearance time,the chest symptoms disappearing time or breathing difficulties disappear time were shorter than that of the control group,comparison between groups with statistical significance(P<0.05).The total satisfaction degree of the children in the experimental group was 95.56%,which was significantly higher than that of the control group (82.22%),and the differences were statistically significant(P<0.05).Conclusion The use of home atomization inhaled glucocorticoids treatment in pediatric respiratory system disease can significantly improve the treatment rate of children,reduce and relieve the clinical symptoms of children,improve the overall treatment effect,it is worth promoting in clinical use.
梅文静;邹莉;方兴;何颖慧;曾雪飞. 家庭雾化吸入糖皮质激素治疗在儿科呼吸系统疾病中的应用价值[J]. 中国当代医药, 2018, 25(8): 77-79.
MEI Wen-jing;ZOU Li;FANG Xing;HE Ying-hui;ZENG Xue-fei. The application value of home atomization inhaled glucocorticoids in the treatment of pediatric respiratory diseases. 中国当代医药, 2018, 25(8): 77-79.